Table 1.
Selected data at inclusion in 41 dogs with CE treated with FMT.
| Parameter | Result (Range (Median) or Number) |
|---|---|
| Age (years) | 0.6–13.0 (5.8) |
| Breeds a | GSD 4, GR 3, MB 3, LR 2, RT 2, WH 2, STDPDL 2, ESS 2, MISC 21 |
| Treated for CE (months) | 1–110 (20) |
| Immunosuppressive treatment | CS b 15, CS + mycophenolate 8, CS + cyclosporine 7, CS + chlorambucil 6, CS + azathioprine 2 |
| Miscellaneous treatment c | Probiotics c 18, olsalazine 13, cobalamin 11, prebiotics d 11, cisapride 3, sucralfate 3, metronidazole 2, mirtazapine 2 |
| Diet e | Hydrolysed protein 28, single protein 11, GI f 2 |
| Main reasons for FMT | Diarrhoea 32, lethargy 18, unable taper CS 13, abdominal pain 13, hyporexia 9, underweight 6, reduce use/need of antibiotics 3 |
a GSD: German Shepherd Dog; GR: Golden Retriever; MB: Mixed breed; LR: Labrador Retriever; RT: Rottweiler; WH: Whippet; STDPDL: Standard Poodle; ESS: English Springer Spaniel; MISC: Miscellaneous breeds represented by 1 individual/breed b CS: corticosteroids (budesonide, methylprednisolone or prednisolone); c multistrain high dose probiotic (SivomixxTM or VivomixxTM); d multi-fibre blend or psyllium; e 38 dogs were fed premium kibble diets from major pet food companies, 3 dogs were fed a home-cooked balanced diet (horse and potato or moose and rice); f GI: gastro-intestinal (easily digestible diet).